Detalhe da pesquisa
1.
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
Blood
; 139(18): 2747-2757, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511184
2.
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.
Rheumatology (Oxford)
; 62(SI): SI32-SI42, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686921
3.
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.
Haematologica
; 106(7): 1867-1875, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527951
4.
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma.
J Oncol Pharm Pract
; 27(7): 1730-1735, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33100177
5.
Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.
Radiology
; 295(3): 651-661, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286191
6.
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.
Am J Hematol
; 2018 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884994
7.
Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Dermatology
; 234(1-2): 23-30, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788024
8.
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
Br J Haematol
; 198(1): 203-206, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445392
9.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
10.
Massive pneumomediastinum due to perforated pneumatosis cystoides in graft-versus-host disease.
Br J Haematol
; 192(6): 948, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238030
11.
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.
Haematologica
; 101(4): 466-73, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768687
12.
Photo-induced graft-versus-host disease.
Photodermatol Photoimmunol Photomed
; 32(5-6): 291-295, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623188
13.
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival.
BMC Cancer
; 15: 288, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884669
14.
Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.
Haematologica
; 99(3): 474-80, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142998
15.
[Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Deuxième allogreffe (mise à jour). Recommandations de la Société francophone de greffe de moelle osseuse et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 111(2S): S29-S39, 2024 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-37045732
16.
Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia.
Haematologica
; 98(1): 65-70, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065520
17.
Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant.
Haematologica
; 98(8): 1185-95, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904236
18.
[Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC]. / Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l'allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC.
Bull Cancer
; 110(2S): S13-S29, 2023 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-36307324
19.
[Cardiac complications following allogeneic hematopoietic stem cell transplantation: Recommendations of the SFGM-TC]. / Complications cardiaques de la greffe de cellules souches hématopoïétiques : recommandations de la SFGM-TC.
Bull Cancer
; 110(2S): S56-S66, 2023 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-35662519
20.
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
J Clin Oncol
; 41(2): 327-335, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867960